Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1

National Institute on Drug Abuse (NIDA)20 enrolled

Overview

The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.

This is a human laboratory clinical pharmacology study to assess potential interactions between IV methamphetamine challenge and treatment with oral sustained-release bupropion.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

DOUBLE

Enrollment

Conditions

Amphetamine-Related Disorders

Interventions

BupropionDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: Please contact site director for more details. Exclusion Criteria: Please contact site director for more details.

Locations (2)

UCLA Integrated Substance Abuse Program

Los Angeles, California, United States

University of Texas Health Science Center

Houston, Texas, United States

Outcomes

Primary Outcomes

Psychological effects

BP, HR

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.